RTK Inhibitors in Melanoma: From Bench to Bedside

SIMPLE SUMMARY: Receptor tyrosine kinases (RTKs) have long been demonstrated to play key roles in melanoma development. RTK activation requires dimerization and intracellular tyrosine trans-phosphorylation leading to downstream signaling pathways activation. As RTKs show different structures, mechan...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabbah, Malak, Najem, Ahmad, Krayem, Mohammad, Awada, Ahmad, Journe, Fabrice, Ghanem, Ghanem E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038208/
https://www.ncbi.nlm.nih.gov/pubmed/33918490
http://dx.doi.org/10.3390/cancers13071685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8038208/
https://www.ncbi.nlm.nih.gov/pubmed/33918490
http://dx.doi.org/10.3390/cancers13071685

Ejemplares similares